What "treatment-resistant anxiety" looks like

You may carry a generalized anxiety, panic, social anxiety, or OCD-spectrum diagnosis. The official cutoff varies by guideline, but functionally it means you’ve tried at least two evidence-based interventions — medications, structured therapy, or both — without sufficient relief. An estimated 40% of people with anxiety disorders don’t respond fully to first-line treatment [1]. That’s a lot of people, and they’re rarely getting the workup that would explain why.

Why standard approaches sometimes aren't enough

Psychiatric medication and CBT both work on real mechanisms — but they assume a system that’s fundamentally functional underneath. When the underlying neurochemistry is being driven by something else (chronic inflammation, blood sugar dysregulation, gut-derived neurotransmitter imbalance, hormonal cycling, methylation defects, or HPA axis hyperdrive), addressing the surface won’t hold the floor.

Anxiety isn’t always a thinking problem. Sometimes it’s a biology problem expressing itself as anxious thoughts.

Right-Image

What could be driving your anxiety

We investigate the systems most strongly implicated in chronic anxiety:

Icons
GABA-glutamate imbalance.

GABA is the brain's primary inhibitory neurotransmitter; glutamate is its primary excitatory one. Imbalances driven by gut microbiome shifts, B6 deficiency, magnesium depletion, or genetic variants in GAD1 produce a baseline state of nervous system hyperarousal.

Icons
HPA axis dysregulation.

Chronically elevated cortisol, dysregulated diurnal rhythm, or impaired DHEA production all contribute to anxiety. DUTCH testing maps the full pattern.

Icons
COMT genetic variants.

"Slow COMT" reduces the breakdown of catecholamines (dopamine, norepinephrine, epinephrine), keeping the nervous system chronically activated [2]. This pattern responds to specific dietary and supplement strategies that wouldn't be obvious without testing.

Icons
Histamine intolerance and mast cell activation.

Excess histamine acts as an excitatory neurotransmitter. People with DAO insufficiency, MCAS, or methylation issues often present with anxiety, insomnia, and food-triggered symptoms.

Icons
Gut-brain dysregulation.

The microbiome produces or regulates GABA, serotonin precursors, and short-chain fatty acids — all directly relevant to anxiety. Dysbiosis tilts the system toward excitatory signaling [3].

Icons
Blood sugar instability.

Reactive hypoglycemia drives adrenaline release that's symptomatically indistinguishable from anxiety. Often missed without continuous glucose monitoring or fasting insulin.

Icons
Subclinical thyroid issues.

Hyperthyroidism mimics anxiety; Hashimoto's antibodies correlate with anxious mood independent of thyroid hormone levels.

Icons
Sex hormone fluctuations.

Premenstrual exacerbation, perimenopausal volatility, and low testosterone in men all show clear links to anxiety severity.

Icons
Nutrient depletion.

Magnesium RBC, vitamin B6, vitamin D, zinc, and omega-3 EPA all have established roles in anxiety regulation.

What we look for in your testing

For anxiety, DUTCH Plus and the GI Effects panel are typically the highest-yield tests — they map the HPA axis and the gut-microbiome-immune triangle that often drives sustained anxiety. Environmental toxins can tell an often overlooked story. KBMO FIT 176 with Gut Barrier Panel reveals food sensitivities and intestinal permeability that often amplify anxious symptoms. NutrEval reveals the nutrient cofactors involved. 3×4 Genetics highlights the COMT, MAO, MTHFR, and GAD variants that change how your nervous system processes stress.

If you’ve already had hormone or gut testing done elsewhere, we integrate it. Bring everything.

How a personalized protocol comes together

The first phase usually focuses on whichever system is showing the most dysregulation — often gut and HPA axis simultaneously, since they’re tightly coupled. Targeted nutrient repletion, gut-supportive interventions, and adaptogenic or calming herbal protocols come together with breath, sleep, and stress-modulation work. Where COMT or methylation variants are central, supplement choices are adjusted accordingly — for slow COMT, methyl donors are introduced cautiously, in stages, with monitoring.

Full program structure main services page.

Background

Is this approach right for you?

This works for people whose anxiety hasn't responded fully to medication or therapy alone, who suspect there's something biological they haven't identified, and who are ready to work systematically through a structured investigation. We don't replace medication. We work alongside it, often in coordination with your prescriber, and frequently see medication doses reduce as the underlying drivers come under control.

References

  • Bystritsky A. Treatment-resistant anxiety disorders. Mol Psychiatry. 2006;11(9):805-14. doi:10.1038/sj.mp.4001852. PMID: 16847460.
  • Domschke K, Deckert J. Genetics of anxiety disorders - status quo and quo vadis. Curr Top Behav Neurosci. 2010;2:63-75. doi:10.1007/7854_2009_30. PMID: 21309106.
  • Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305-12. doi:10.1016/j.tins.2013.01.005. PMID: 23384445.